ATE427119T1 - Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung - Google Patents

Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE427119T1
ATE427119T1 AT02801021T AT02801021T ATE427119T1 AT E427119 T1 ATE427119 T1 AT E427119T1 AT 02801021 T AT02801021 T AT 02801021T AT 02801021 T AT02801021 T AT 02801021T AT E427119 T1 ATE427119 T1 AT E427119T1
Authority
AT
Austria
Prior art keywords
production
rabies vaccine
recombinant rabies
rabies virus
recombinant
Prior art date
Application number
AT02801021T
Other languages
English (en)
Inventor
Bernhard Dietzschold
Douglas Craig Hooper
Matthias Schnell
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of ATE427119T1 publication Critical patent/ATE427119T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02801021T 2001-10-10 2002-10-10 Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung ATE427119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32835001P 2001-10-10 2001-10-10

Publications (1)

Publication Number Publication Date
ATE427119T1 true ATE427119T1 (de) 2009-04-15

Family

ID=23280622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02801021T ATE427119T1 (de) 2001-10-10 2002-10-10 Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung

Country Status (6)

Country Link
US (1) US7223584B2 (de)
EP (1) EP1439856B1 (de)
AT (1) ATE427119T1 (de)
CA (1) CA2463090C (de)
DE (1) DE60231821D1 (de)
WO (1) WO2003030933A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923029B2 (en) * 2002-04-11 2011-04-12 Medimmune Llc Spray freeze dry of compositions for pulmonary administration
RS51371B (sr) 2004-07-12 2011-02-28 Thomas Jefferson University, Office Of Technology Transfer Smeše rekombinantnog rabijes virusa
CA2943039C (en) 2005-10-14 2018-11-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus compositions and methods
CN102159240B (zh) * 2008-09-17 2014-12-24 美国政府健康及人类服务部，疾病控制和预防中心 基于狂犬病毒的重组免疫避孕组合物及其使用方法
US8282939B2 (en) * 2009-09-11 2012-10-09 Thomas Jefferson University Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies
CN101768575B (zh) * 2010-01-15 2013-06-12 中国农业科学院哈尔滨兽医研究所 双表达g基因的重组狂犬病病毒的构建及其生物学特性分析
RU2013102929A (ru) * 2010-06-24 2014-07-27 Зе Гавермент Оф Зе Юнайтед Стейтс Оф Америка Эз Репрезентед Бай Зе Секретари Оф Зе Департмент Оф Хэлс Энд Хьюман Сервисез, Сентерз Фо Дизиз Контрол Энд Привеншн Пан-лиссавирусные вакцины против бешенства
CN103323588A (zh) * 2012-03-19 2013-09-25 郑州中道生物技术有限公司 一种犬狂犬病毒抗体的检测方法及检测试剂盒
WO2014055289A1 (en) * 2012-10-01 2014-04-10 Thomas Jefferson University Immunization with rabies virus vector expressing foreign protein antigen
CN104599668B (zh) * 2014-12-18 2018-02-02 清华大学 基于稀疏矩阵快速语音识别方法和装置
CN117700522A (zh) * 2023-12-14 2024-03-15 吉林大学 宿主因子Snapin在狂犬病病毒新型疫苗和救治药物研制中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693655B1 (fr) 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
US6295531B1 (en) * 1998-11-09 2001-09-25 Unisys Corporation Cool ICE data wizard
US7074413B2 (en) 2000-03-23 2006-07-11 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
US6708173B1 (en) * 2000-10-18 2004-03-16 Unisys Corporation Method and apparatus for multiple application trace streams
US6836886B2 (en) * 2001-03-19 2004-12-28 Autodesk, Inc. Method and apparatus for delivering electronic information

Also Published As

Publication number Publication date
EP1439856A1 (de) 2004-07-28
US20030113346A1 (en) 2003-06-19
US7223584B2 (en) 2007-05-29
EP1439856A4 (de) 2005-01-19
CA2463090A1 (en) 2003-04-17
CA2463090C (en) 2012-06-12
WO2003030933A1 (en) 2003-04-17
DE60231821D1 (de) 2009-05-14
EP1439856B1 (de) 2009-04-01

Similar Documents

Publication Publication Date Title
ATE527281T1 (de) Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte
DE60139026D1 (de) Lebender influenza impfstoff und verfahren zu seiner herstellung
CY1106785T1 (el) Ιικα σωματιδια τα οποια απελευθερωνονται μετα απο μολυνση απο ανθρωπινο κυτταρομεγαλοϊο και η χρηση τους ως εμβολιο
WO2005062820A3 (en) Multi plasmid system for the production of influenza virus
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
ATE396739T1 (de) Entwicklung einer vakzine zur prävention von infektionen mit filovirus bei primaten
ATE526411T1 (de) Avirulente, immunogene flavivirus-chimäre
EA200501890A1 (ru) Вирусы гриппа высокого титра для приготовления вакцин и генной терапии
NO20041157L (no) HIV-GAG kodonoptimaliserte DNA-vaksiner
FR2827605B1 (fr) Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
ATE427119T1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
GB2386072A (en) Novel vaccine
MY128999A (en) Purification of hbv antigens for use in vaccines
WO2003066094A3 (en) Hepatitis b vaccines
ATE372129T1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
DK1272652T3 (da) Herpesvirus til immunmodulation
CY1107784T1 (el) Πρωτεϊνη συντηξης g του ihnv για διεγερση του ανοσοποιητικου συστηματος
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
NO20020615L (no) Vaksine
EP1427443A4 (de) Vakzine mit papilloma-virus-e-proteinen, die durch einen viralen vektor abgegeben werden
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
TW200509964A (en) VP1 of foot-and-mouth disease virus
ATE283066T1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
ATE526034T1 (de) Verbesserte inaktivierte fcv-vakzinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties